May 9, 2018 - Press Releases
£1.45 million grant from Innovate UK Biomedical Catalyst Funds enable IGEM Therapeutics to progress second product candidate towards the clinic London, 9 May 2018 – IGEM Therapeutics (IGEM), an immuno-oncology company developing novel...
April 9, 2018 - Press Releases
Cambridge, UK, 04 April 2018: IONTAS Limited (IONTAS), a leader in the discovery and optimisation of fully human antibodies, announced today that it will collaborate with Epsilogen (IGEM), an immuno-oncology company developing novel...
August 11, 2017 - Press Releases
Raises £2 million from Epidarex Capital to progress pipeline of IgE antibody drug candidates to treat cancer
